Tags Archives: ecmo

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is required for patients with refractory cardiac or respiratory failure. Inadequate securement of ECMO cannulae may lead to adverse events, ranging from line kinking to..

Perfusfind S.L.

Abstract Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is a form of mechanical support used in respiratory failure refractory to conventional medical management. Because VV ECMO cannulation is an uncommonly performed,..

Perfusfind S.L.

Abstract Medical simulation provides a realistic environment for practitioners to experience a planned clinical event in a controlled educational setting. We established a simulation model composed of synthetic ballistic gelatin..

Perfusfind S.L.

Abstract Background Major airway surgery can pose a complex problem to perioperative central airway management. Adjuncts to advanced ventilation strategies have included cardiopulmonary bypass (CPB), veno-arterial (VA-ECLS) or veno-venous extracorporeal..

Perfusfind S.L.

ECMO usage, the number of patients being considered for ECMO therapy and the number of ECMO platforms has exploded during the last two years. Joe will explore the number of..

Perfusfind S.L.

Adult Certified ECMO Specialist™ (CES-A™) Exam The American Society of ExtraCorporeal Technology (AmSECT) and the International Board of Blood Management (IBBM) are pleased to announce the first Adult ECMO Specialist..

Perfusfind S.L.

Abstract Introduction The impact of Impella and ECMO (ECPELLA) in  (CS) remains to be defined. The aim of this meta-analysis is to evaluate the benefit of ECPELLA compared to VA-ECMO in..

Perfusfind S.L.

Abstract Background: Extracorporeal membrane oxygenation (ECMO) is increasingly utilized for pediatric sepsis unresponsive to steroids and inotropic support. Outcomes of children with sepsis are influenced by the type of pathogen causing..

Perfusfind S.L.

Apresentação da Perfusionista Selma Antero a convite da empresa Livanova para falar sobre protocolos da ECMO na Covid-19.          

Perfusfind S.L.

Abstract Une unité spéciale de médecins pratique des opérations cardiaques au plus près des malades, sur les trottoirs de… Paris ! De la médecine "de guerre" en temps de paix. Un..

Perfusfind S.L.

Abstract Background:  The use of extracorporeal membrane oxygenation (ECMO) in coronavirus disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and bridge to lung transplantation has been steadily increasing..

Perfusfind S.L.

Abstract Accidental hypothermia (AH) in Mediterranean countries often is underestimated. AH should be suspected in patients also in moderate climates throughout all seasons. Compared with other countries, the mortality rate..

Perfusfind S.L.

Abstract Background: To assess the impact of diagnostic procedures in identifying residual lesions during extracorporeal membrane oxygenation (ECMO) on survival after pediatric cardiac surgery. Methods: Between January 2012 and December..

Perfusfind S.L.

  EuroELSO Webinar on 30 March 2021 Topic: Anticoagulation monitoring on ECMO in neonates and children: moving target - anti Xa over ACT & APTT.   Introduction, moderation & closing..

Perfusfind S.L.

Equipo de Cirugía Cardiovascular Hospital Christus Muguerza. Monterey. Nuevo León. México. -Dr Guillermo Quezada. Cirujano Cardiovascular Pediátrico. -Dr Rosemberg Albores. Anestesiólogo Cardiovascular -Dr Cesar Hernandez. Intensivista Pediátra. Moderadora: Perf Maria..

Perfusfind S.L.

Abstract Refractory cardiogenic shock (CS) often requires veno-arterial extracorporeal membrane oxygenation (VA-ECMO) to sustain end-organ perfusion. Current animal models result in heterogenous cardiac injury and frequent episodes of refractory ventricular..

Perfusfind S.L.

Patient with Covid 19 and LV failure refractory under mechanical ventilation to the treatment undergone central ECMO with inflow access right femoral vein and outflow access to the ascending aorta..

Perfusfind S.L.

Abstract Extracorporeal Membrane Oxygenation (ECMO) is commonly associated with a high blood transfusion requirement. Jehovah’s Witness patients present a particular challenge. The impossibility of transfusing blood cells and starting anticoagulation..

Perfusfind S.L.

Abstract Background: The prevalence of delirium and its association with long-term outcomes of extracorporeal membrane oxygenation (ECMO) therapy have not yet been identified. We aimed to investigate the prevalence of delirium..

Perfusfind S.L.

ABSTRACT In 1952, John Gibbon performed the first successful cardiac procedure using cardiopulmonary bypass, which turned out to be one of the most important clinical advances of that year. Cardiopulmonary..

Perfusfind S.L.

Abstract We present the case of a 13-year-old male with a complex congenital cardiac history who was supported with extracorporeal membrane oxygenation for 394 days while awaiting cardiac transplantation. The..

Perfusfind S.L.

Abstract Background: The aim of this study was to determine epidemiology and outcomes of acute kidney injury (AKI) in patients on extracorporeal membrane oxygenation (ECMO) and to assess if age modifies..

Perfusfind S.L.

Abstract Background Extracorporeal cardiopulmonary resuscitation (eCPR) is a rapidly growing treatment strategy due to increasing survival rates in selected patients. Additional left ventricular mechanical unloading, using a transfemoral micro-axial blood..

Perfusfind S.L.

Abstract Background Over the course of the COVID-19 pandemic, the care of patients with COVID-19 has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased. We aimed to..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is a common treatment for cardiopulmonary failure. Although it can effectively reduce the mortality of patients with cardiopulmonary failure, it still has a high mortality..

Perfusfind S.L.

Abstract The coronavirus disease 2019 (COVID-19) pandemic began in the United States around March 2020. Because of limited access to extracorporeal membrane oxygenation (ECMO) in the authors’ region, a mobile..

Perfusfind S.L.

Lilliput 2 ECMO is the new version completing the Lilliput oxygenators' family. Equipped with a long-term usage validated polymethylpentene membrane, it guarantees optimal performance for neonatal and infant patients undergoing..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is used in critical care to manage patients with severe respiratory and cardiac failure. ECMO brings blood from a critically ill patient into contact with..

Perfusfind S.L.

Hypoxic-ischemic brain injury is the main cause of death or disability in patients resuscitated from cardiac arrest (CA). Veno-arterial extracorporeal membrane oxygenation (VA ECMO) may be used as a mechanical support for..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) provides lifesaving circulatory support and gas exchange, although hematologic complications are frequent. The relationship between ECMO and severe thrombocytopenia (platelet count <50 × 109/L) remains ill-defined. We performed..